The <em>National Law Journal</em> notes Fried Frank's representation of Ariad Pharmaceuticals in the upcoming en banc rehearing before the Federal Circuit Court of Appeals in <em>Ariad vs. Eli Lilly</em>

The National Law Journal notes Fried Frank's representation of Ariad Pharmaceuticals in the upcoming en banc rehearing before the Federal Circuit Court of Appeals in Ariad vs. Eli Lilly

The National Law Journal reports on the upcoming en banc rehearing before the Federal Circuit Court of Appeals in Ariad vs. Eli Lilly.  The en banc court will tackle whether the patent code requires a specific "written description" of the claimed invention in addition to enabling language, which explains how to make and use it. Fried Frank represents Ariad Phamaceuticals in the appeal.

news-detail.inc